Measles-containing-vaccine first-dose (MCV1) immunization coverage in Azerbaijan
Azerbaijan: Measles-containing-vaccine first-dose (MCV1) immunization coverage was 71.0% in 2025. ▬ Flat
Latest (2025)
71.0%
Change on year
unchanged
World rank
159th
of 194 countries
All-time high
89.0%
in 2010
All-time low
61.0%
in 2020
Years of data
26
2000–2025
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Azerbaijan, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine first-dose (mcv1) immunization coverage in Azerbaijan stood at 71.0%.
Compared with earlier readings it is down 15.5% over ten years.
Over the whole period, measles-containing-vaccine first-dose (mcv1) immunization coverage in Azerbaijan peaked at 89.0% in 2010 and was at its lowest, 61.0%, in 2020.
That places Azerbaijan 159th out of 194 countries with data for 2025, putting it in the bottom quarter.
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Azerbaijan, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 67.0% | — |
| 2001 | 68.0% | +1.5% |
| 2002 | 66.0% | -2.9% |
| 2003 | 67.0% | +1.5% |
| 2004 | 67.0% | +0.0% |
| 2005 | 67.0% | +0.0% |
| 2006 | 69.0% | +3.0% |
| 2007 | 75.0% | +8.7% |
| 2008 | 79.0% | +5.3% |
| 2009 | 85.0% | +7.6% |
| 2010 | 89.0% | +4.7% |
| 2011 | 88.0% | -1.1% |
| 2012 | 86.0% | -2.3% |
| 2013 | 86.0% | +0.0% |
| 2014 | 85.0% | -1.2% |
| 2015 | 84.0% | -1.2% |
| 2016 | 81.0% | -3.6% |
| 2017 | 80.0% | -1.2% |
| 2018 | 77.0% | -3.8% |
| 2019 | 78.0% | +1.3% |
| 2020 | 61.0% | -21.8% |
| 2021 | 66.0% | +8.2% |
| 2022 | 71.0% | +7.6% |
| 2023 | 71.0% | +0.0% |
| 2024 | 71.0% | +0.0% |
| 2025 | 71.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 71.0% | 66.0% | 85.0% | 10 |
| 2010s | 83.4% | 77.0% | 89.0% | 10 |
| 2020s | 68.5% | 61.0% | 71.0% | 6 |
Countries ranked near Azerbaijan
More health data for Azerbaijan
- Un projection of annual infant deaths, annual growth rate -1.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1127 % change on previous year (2090)
- Heat deaths vs projected death rates 1,241 (2090)
- Un projection of annual infant deaths 264 (2100)
- Population ages 0-14, female, annual growth rate -2.37 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1004 units per person (2025)
- Population ages 0-14, male, annual growth rate -2.39 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1116 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine first-dose (mcv1) immunization coverage in Azerbaijan?
- Measles-containing-vaccine first-dose (mcv1) immunization coverage in Azerbaijan was 71.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Azerbaijan?
- The highest recorded value was 89.0% in 2010.
- What is the lowest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Azerbaijan?
- The lowest recorded value was 61.0% in 2020.
- How does Azerbaijan rank for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Azerbaijan ranks 159th out of 194 countries with data for 2025.
- Is measles-containing-vaccine first-dose (mcv1) immunization coverage rising or falling in Azerbaijan?
- Over the last ten years it is down 15.5%. The long-run trend across the full record is flat.
- Where does this Azerbaijan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).